Research Insight
Pfizer’s Trumenba gets FDA accelerated approval to treat Meningococcal...
US-based drugmaker Pfizer has received accelerated approval from US Food and Drug Administration (FDA) for its Trumenba to treat Meningococcal B disease in...
Research Insight
Hikma to market Eisai’s epilepsy treatment Fycompa in Middle...
UK-based Hikma Pharmaceuticals has partnered with Eisai to distribute first-class epilepsy treatment Fycompa (perampanel) in the Middle East. Eisai has...
Research Insight
Gilead’s Harvoni receives FDA approval for hepatitis C genotype...
Gilead Sciences has received approval from US Food and Drug Administration for Harvoni (ledipasvir 90mg/sofosbuvir 400mg), a once-daily single tablet regimen to treat...
Research Insight
EMD Serono, ICR and Wellcome Trust partner develop anti-cancer...
Merck subsidiary EMD Serono, The Institute of Cancer Research (ICR) and the Wellcome Trust have entered into a co-development and licence agreement for...
Research Insight
Novartis and BMS enter clinical collaboration to assess lung...
Swiss drug maker Novartis has partnered with US-based Bristol-Myers Squibb (BMS) to assess the safety, tolerability and preliminary efficacy of its three molecularly...
Research Insight
UK’s Medical Research Council grants fund for three new...
The UK Medical Research Council (MRC) has granted a fund of £6m for three new research programmes, as part of a £60m investment. The ...
Research Insight
Afatinib drug could inhibit growth of womb cancer, say...
Research conducted by scientists from the Yale School of Medicine gynaecologic oncology division has demonstrated that the drug afatinib could inhibit the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.